Deloitte’s public sector team recently acquired Gryphon Scientific, a public health research and consulting company known for its expertise in artificial intelligence. This move will enhance Deloitte’s ability to collaborate with federal and government agencies on utilizing AI and other data-centric tools to detect and respond to infectious diseases. The terms of the transaction were not disclosed.
Established in 2005, Gryphon Scientific employs a team of scientists, programmers, and policy specialists with experience in data science, scientific communications, modeling, and risk assessment. The company has utilized AI in its research efforts to analyze biological and chemical threats and was a founding member of the U.S. Artificial Intelligence Safety Institute Consortium managed by the National Institute of Standards and Technology.
According to USASpending.gov data, Gryphon has received approximately $5.5 million in unclassified prime contract obligations in the past 12 months, primarily from the departments of Homeland Security, Health and Human Services, and Defense. With Gryphon now under Deloitte’s umbrella, the public sector team aims to enhance its capacity in developing practical AI solutions in health and establish trust in the technology through its Federal Health AI Accelerator organization.
Deloitte intends to expand its expertise in biosecurity, lab safety, data science, and global and domestic emergency preparedness and response by incorporating the Gryphon team into its operations. This acquisition marks a significant step in Deloitte’s commitment to leveraging AI for the benefit of public health and safety initiatives.
In summary, Deloitte has acquired Gryphon Scientific to enhance its ability to collaborate with federal agencies on utilizing AI for infectious disease detection and response. The acquisition also strengthens Deloitte’s expertise in biosecurity, lab safety, data science